Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Efficient co-delivery of neo-epitopes using dispersion-stable layered double hydroxide nanoparticles for enhanced melanoma immunotherapy.

Biomaterials - 1 Aug 2018

Zhang Ling-Xiao, Xie Xi-Xiu, Liu Dong-Qun, Xu Zhi Ping, Liu Rui-Tian

Abstract excerpt

Cancer immunotherapy has shown tremendous progresses in recent years for various cancers and layered double hydroxide (LDH) nanoparticles are demonstrated as effective adjuvants for protein-based vaccines. This research further shows that the colloidal stability of LDH-based vaccines significantly influences the therapeutic efficacy and LDH nanoparticles are able to adjuvant multiple tumor-associated antigen...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adjuvants, Immunologic
Share to Antigens, Neoplasm

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cancer Vaccines

Share to Intramolecular Oxidoreductases

Share to Nanoparticles

Share to Particle Size

Share to Surface Properties

Share to T-Lymphocytes, Cytotoxic

Source

Identifiers

PMID: 29778982
DOI: 10.1016/j.biomaterials.2018.05.015

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Efficient co-delivery of neo-epitopes using dispersion-stable layered double hydroxide nanoparticles for enhanced melanoma immunotherapy.PMID 29778982Read ↗

Lipid-Glycoadjuvant@AuNPs Inhibits Tumor Gowth and Regulates Tumor Microenvironments by Tumor-Specific CTL-Ferived IFNγSemantic proximity Read ↗

Carrier-Free Nanovaccine: An Innovative Strategy for Ultrahigh Melanoma Neoantigen LoadingSemantic proximity Read ↗

Effective oral delivery of gp100 plasmid vaccine against metastatic melanoma through multi-faceted blending-by-blending nanogels.Semantic proximity Read ↗

Targeting Mutated Plus Germline Epitopes Confers Pre-clinical Efficacy of an Instantly Formulated Cancer Nano-VaccineSemantic proximity Read ↗

Manganese-Doped Silica-Based Nanoparticles Promote the Efficacy of Antigen-Specific Immunotherapy.Semantic proximity Read ↗

Efficient Nanovaccine Delivery in Cancer ImmunotherapySemantic proximity Read ↗

Endogenous/Exogenous Nanovaccines Synergistically Enhance Dendritic Cell-mediated Tumor ImmunotherapySemantic proximity Read ↗

A homologous-targeting "nanoconverter" with variable size for deep tumor penetration and immunotherapy.Semantic proximity Read ↗

Electrostatically Assembled CaO2@MPN-HA Nanoreactors Potentiate Anti-PD-1 Therapy in Thyroid Cancer via Synergistic Ferroptosis and Calcium OverloadSemantic proximity Read ↗

Self-assembled peptide/polymer hybrid nanoplatform for cancer immunostimulating therapiesSemantic proximity Read ↗

High-Density Wild-Type IL-2 Nanoparticles Preferentially Enhance CD8⁺ T-Cell Expansion and Reprogram the Tumor MicroenvironmentSemantic proximity Read ↗

TCR-engaging scaffolds selectively expand antigen-specific T-cells with a favorable phenotype for adoptive cell therapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.